Incyte (NASDAQ: INCY) strength recently was tied to AbbVie's (NYSE: ABBV) M&A commentary on Tuesday, according ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE